IE 11 is a very old browser and is not supported on this site.

Organic growth of net sales

Organic growth of net sales shows the development of net sales for the operating segments Products & Care and Logistics & IT excluding the effects of acquisitions, new license agreements, openings and closures of pharmacies (effect of net expansion). It provides a “like-for-like” comparison with previous periods. In the business area Retail (B2C), organic growth of net sales is calculated only including points of sales with a full year period comparison. In the business area Professionals (B2B), organic growth of net sales is calculated only including existing business activities with a full year period comparison. In order to show the impact of mandatory price reductions of medications reimbursed by health insurers on net sales transparently, organic growth of net sales is also disclosed without the effect of mandatory price reductions.

Organic growth of net sales 2023

in thousand CHF

Retail (B2C)

Professionals (B2B)

Products & Care 1)

Wholesale

Logistics & IT Services

Logistics & IT 1)

Net sales

1,385,564

256,064

1,635,633

2,952,732

143,965

3,076,988

Change to previous period

1.8%

11.9%

3.3%

4.7%

10.1%

4.9%

 

 

 

 

 

 

 

Effect of net expansion

3,979 2)

12,686 3)

16,666

928 3)

928

In % of net sales of previous period

0.3%

5.5%

1.1%

0.0%

0.7%

0.0%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

1,381,584

243,378

1,618,967

2,952,732

143,037

3,076,059

Organic growth of net sales

1.5%

6.4%

2.2%

4.7%

9.4%

4.9%

 

 

 

 

 

 

 

Mandatory price reductions 4)

18,069

 

 

51,300

 

 

In % of net sales of previous period

1.3%

 

 

1.8%

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

1,399,653

 

 

3,004,032

 

 

Organic growth of net sales excluding price reductions

2.8%

 

 

6.5%

 

 

1) Including eliminations of intercompany net sales

2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales 2023 Products & Care

in thousand CHF

Local Pharmacies

Pharmacies at Home

Retail (B2C) 1)

Products & Brands

Services for Professionals

Professionals (B2B) 1)

Net sales

1,306,931

78,918

1,385,564

177,132

78,934

256,064

Change to previous period

1.6%

6.6%

1.8%

12.3%

11.0%

11.9%

 

 

 

 

 

 

 

Effect of net expansion

2,069 2)

1,911 2)

3,979 2)

11,449 3)

1,237 3)

12,686 3)

In % of net sales of previous period

0.2%

2.6%

0.3%

7.3%

1.7%

5.5%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

1,304,862

77,008

1,381,584

165,683

77,697

243,378

Organic growth of net sales

1.4%

4.0%

1.5%

5.0%

9.3%

6.4%

 

 

 

 

 

 

 

Mandatory price reductions 4)

18,069

 

18,069

 

 

 

In % of net sales of previous period

1.4%

 

1.3%

 

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

1,322,931

 

1,399,653

 

 

 

Organic growth of net sales excluding price reductions

2.8%

 

2.8%

 

 

 

1) Including eliminations of intercompany net sales

2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales 2022

in thousand CHF

Retail (B2C) 1)

Professionals (B2B)

Products & Care 1) 2)

Wholesale

Logistics & IT Services

Logistics & IT 2)

Net sales

1,360,718

228,780

1,583,959

2,820,359

130,712

2,933,318

Change to previous period 3)

2.7%

17.9%

4.7%

3.4%

16.8%

3.6%

 

 

 

 

 

 

 

Effect of net expansion

7,498 4)

17,972 5)

25,469

682

682

In % of net sales of previous period

0.6%

9.3%

1.7%

0.0%

0.6%

0.0%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

1,353,221

210,809

1,558,490

2,820,359

130,030

2,932,636

Organic growth of net sales 3)

2.1%

8.6%

3.0%

3.4%

16.2%

3.6%

 

 

 

 

 

 

 

Mandatory price reductions 6)

16,672

 

 

57,520

 

 

In % of net sales of previous period

1.3%

 

 

2.1%

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

1,369,893

 

 

2,877,879

 

 

Organic growth of net sales excluding price reductions 3)

3.3%

 

 

5.5%

 

 

1) Figures restated (refer to note 4 of the Consolidated financial statements 2023 of the Galenica Group)

2) Including eliminations of intercompany net sales

3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 1.6% lower for Retail (B2C), 1.4% lower for Products & Care and 0.6% higher for Wholesale and Logistics & IT

4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Organic growth of net sales 2022 Products & Care

in thousand CHF

Local Pharmacies

Pharmacies at Home 1)

Retail (B2C) 1) 2)

Products & Brands

Services for Professionals

Professionals (B2B) 2)

Net sales

1,286,856

74,032

1,360,718

157,687

71,093

228,780

Change to previous period 3)

2.0%

16.2%

2.7%

19.8%

13.9%

17.9%

 

 

 

 

 

 

 

Effect of net expansion

7,835 4)

–337 4)

7,498 4)

8,771 5)

9,200 5)

17,972 5)

In % of net sales of previous period

0.6%

–0.5%

0.6%

6.7%

14.7%

9.3%

 

 

 

 

 

 

 

Net sales excluding effect of net expansion

1,279,021

74,369

1,353,221

148,916

61,893

210,809

Organic growth of net sales 3)

1.4%

16.7%

2.1%

13.1%

–0.8%

8.6%

 

 

 

 

 

 

 

Mandatory price reductions 6)

16,672

 

16,672

 

 

 

In % of net sales of previous period

1.3%

 

1.3%

 

 

 

 

 

 

 

 

 

 

Net sales excluding effect of net expansion and mandatory price reductions

1,295,693

 

1,369,893

 

 

 

Organic growth of net sales excluding price reductions 3)

2.7%

 

3.3%

 

 

 

1) Figures restated (refer to note 4 of the Consolidated financial statements 2023 of the Galenica Group)

2) Including eliminations of intercompany net sales

3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 24.5% lower for Pharmacies at Home and 1.6% lower for Retail (B2C)

4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)

5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)

6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer